Literature DB >> 20486767

Stabilization of α-conotoxin AuIB: influences of disulfide connectivity and backbone cyclization.

Erica S Lovelace1, Sunithi Gunasekera, Charlotta Alvarmo, Richard J Clark, Simon T Nevin, Anton A Grishin, David J Adams, David J Craik, Norelle L Daly.   

Abstract

α-Conotoxins are peptides isolated from the venom ducts of cone snails that target nicotinic acetylcholine receptors (nAChRs). They are valuable pharmacological tools and have potential applications for treating a range of conditions in humans, including pain. However, like all peptides, conotoxins are susceptible to degradation, and to enhance their therapeutic potential it is important to elucidate the factors contributing to instability and to develop approaches for improving stability. AuIB is a unique member of the α-conotoxin family because the nonnative "ribbon" disulfide isomer exhibits enhanced activity at the nAChR in rat parasympathetic neurons compared with the native "globular" isomer. Here we show that the ribbon isomer of AuIB is also more resistant to disulfide scrambling, despite having a nonnative connectivity and flexible structure. This resistance to disulfide scrambling does not correlate with overall stability in serum because the ribbon isomer is degraded in human serum more rapidly than the globular isomer. Cyclization via the joining of the N- and C-termini with peptide linkers of four to seven amino acids prevented degradation of the ribbon isomer in serum and stabilized the globular isomers to disulfide scrambling. The linker length used for cyclization strongly affected the relative proportions of the disulfide isomers produced by oxidative folding. Overall, the results of this study provide important insights into factors influencing the stability and oxidative folding of α-conotoxin AuIB and might be valuable in the design of more stable antagonists of nAChRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486767     DOI: 10.1089/ars.2009.3068

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.

Authors:  Xiaosa Wu; Yen-Hua Huang; Quentin Kaas; Peta J Harvey; Conan K Wang; Han-Shen Tae; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2017-08-28       Impact factor: 5.157

Review 2.  Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Authors:  Luis M Tuesta; Christie D Fowler; Paul J Kenny
Journal:  Biochem Pharmacol       Date:  2011-06-29       Impact factor: 5.858

3.  Making Ends Meet: Microwave-Accelerated Synthesis of Cyclic and Disulfide Rich Proteins Via In Situ Thioesterification and Native Chemical Ligation.

Authors:  Sunithi Gunasekera; Teshome L Aboye; Walid A Madian; Hesham R El-Seedi; Ulf Göransson
Journal:  Int J Pept Res Ther       Date:  2012-10-14       Impact factor: 1.931

4.  Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB.

Authors:  Xincan Li; Shuai Wang; Xiaopeng Zhu; Dongting Zhangsun; Yong Wu; Sulan Luo
Journal:  Mar Drugs       Date:  2020-03-29       Impact factor: 5.118

Review 5.  α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.

Authors:  Adam C Kennedy; Alessia Belgi; Benjamin W Husselbee; David Spanswick; Raymond S Norton; Andrea J Robinson
Journal:  Toxins (Basel)       Date:  2020-08-06       Impact factor: 4.546

Review 6.  Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails.

Authors:  Nikita Abraham; Richard J Lewis
Journal:  Mar Drugs       Date:  2018-06-13       Impact factor: 5.118

Review 7.  Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders.

Authors:  Andreina Baj; Michela Bistoletti; Annalisa Bosi; Elisabetta Moro; Cristina Giaroni; Francesca Crema
Journal:  Toxins (Basel)       Date:  2019-07-31       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.